Supplementary Figure 3 from VTX-2337 Is a Novel TLR8 Agonist That Activates NK Cells and Augments ADCC
Year: 2023
Type: supplementary-materials
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: gold
OpenAlex ID: W4361902585
